Paper Details

  1. Home
  2. Paper Details

Assessing the cost-effectiveness of switching from a beta-blocker to latanoprost in the treatment of ocular hypertension.

Author: CostagliolaCiro, ParmeggianiFrancesco, SebastianiAdolfo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Glaucoma is treated by lowering intraocular pressure (IOP). Beta-blockers and latanoprost are two commonly used medications. While beta-blockers are generally cheaper and well-established, latanoprost is newer and may be more effective. The decision to switch from beta-blockers to latanoprost should only be made when there is further deterioration in vision despite significant IOP reduction.
Paper Details　
Original Abstract of the Article :
Glaucoma is a pathological condition whose most important risk factor is increased intraocular pressure (IOP). The medical treatment of glaucoma essentially consists of compounds that are able to decrease the IOP. The compounds discussed in this review act in a different way, beta-blockers mainly in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/14656566.4.10.1775

データ提供：米国国立医学図書館（NLM）

Cost-Effectiveness of Switching from Beta-Blockers to Latanoprost in Ocular Hypertension

This article examines the cost-effectiveness of switching from beta-blockers to latanoprost in the treatment of ocular hypertension. The researchers compare the efficacy, safety, and cost of these two drug classes, highlighting their distinct mechanisms of action and potential benefits and risks.

Comparing Treatments for Ocular Hypertension

The article concludes that switching from beta-blockers to latanoprost may be justified in cases of further visual field deterioration despite adequate IOP reduction, poor compliance, or the development of side effects. However, the decision should be based on a careful evaluation of the patient's individual needs and the potential benefits and risks associated with each treatment option.

Managing Ocular Hypertension

This research provides valuable insights for clinicians managing ocular hypertension. It emphasizes the importance of individualized treatment strategies, considering factors such as visual field progression, compliance, and side effects.

Dr.Camel's Conclusion

Like a camel choosing its path through the desert, we must carefully consider the best course of action for managing ocular hypertension. This article provides a cost-effectiveness analysis of different treatment options, guiding us towards strategies that optimize both clinical outcomes and patient well-being.

Date :
  1. Date Completed 2003-12-18
  2. Date Revised 2019-09-16
Further Info :

Pubmed ID

14521487

DOI: Digital Object Identifier

10.1517/14656566.4.10.1775

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.